405 LS 洗板机

下载文档获取更多信息提交一个咨询

The 405™ LS Microplate Washer is the fifth generation BioTek washer, known for superior performance and reliability for washing protocols ranging from gentle cell washing to vigorous ELISAs. The 405 LS has a simple user interface for creation and execution of wash, dispense, aspirate and maintenance protocols within the extensive onboard software. For use under computer control, BioTek’s LHC™ Software is available in standard and 21 CFR Part 11 compliant versions. The optional BioStack™ is available for walk-away automation of up to 50 microplates.

应用

除了标准的分液/抽吸实验外，405 LS在LHC软件的操控下还可以进行多种自动化液体处理功能，非常适合与全自动化系统联用。

ELISA
微珠洗涤
细胞洗涤 /换液

Fluorescence calibration curves for a 13-plex human metabolic hormone panel, using magnetic microspheres washed on the 405.

13种人代谢相关激素的荧光标准曲线，实验使用了405的磁珠洗涤功能。

特点

Intuitive onboard User Interface or LHC™ pc software

The 405 LS has a simple user interface for creation and execution of wash, dispense, aspirate and maintenance protocols within the extensive onboard software. For use under computer control, BioTek’s LHC™ Software is available in standard and 21 CFR Part 11 compliant versions.

Magnetic and polystyrene bead assays, conventional ELISAs

The 405 LS is ideal for many standard plate washing and dispensing protocols, but it also automates more complex operations like magnetic and polystyrene bead washing workflows – and it’s Luminex® xMap® approved. Bead washing is available for 96- and 384-well microplates.

Dual-Action™ manifold

With its angled dispense tubes and adjustable flow rates, the 405 LS can process sensitive cell-based assays. The optional Dual-Action manifold and carrier offer X-Y-Z adjustment, perfect for optimizing plate positioning and residual removal for cell-based and other assays.

产品概览

>> MORE

用户风采

Live SARS-CoV-2 Research: Interlocking Pieces Working Together

9-June-20

When Dr. Robert Davey started researching Ebola virus drug development at the University of Texas Medical Branch (UTMB) at Galveston back in 2008, he had no idea just how keenly his work would prepare him to play a pivotal role in researching treatments for a very different global pandemic. In fact, a number of pieces fit together to support his current role in screening small molecule compounds that may be used in the fight against SARS-CoV-2, the novel coronavirus that causes COVID-19.